Nosology and classification of genetic skeletal disorders: 2010 revision

Matthew L. Warman(Howard Hughes Medical Institute), Valérie Cormier‐Daire(Hôpital Necker-Enfants Malades), Christine M Hall(University of London), Deborah Krakow(Cedars-Sinai Medical Center), Ralph Lachman(Cedars-Sinai Medical Center), Martine LeMerrer(Hôpital Necker-Enfants Malades), Geert Mortier(University of Antwerp), Stefan Mundlos(Max Planck Society), Gen Nishimura(Tokyo Metropolitan Children's Medical Center), David L. Rimoin(Cedars-Sinai Medical Center), Stephen P. Robertson(University of Otago), Ravi Savarirayan(Royal Children's Hospital), David Sillence(The University of Sydney), J Spranger(University of Freiburg), Sheila Unger(University of Freiburg), Bernhard Zabel(University of Freiburg), Andrea Superti‐Furga(University of Freiburg)
American Journal of Medical Genetics Part A
March 15, 2011
Cited by 715Open Access
Full Text

Abstract

Genetic disorders involving the skeletal system arise through disturbances in the complex processes of skeletal development, growth and homeostasis and remain a diagnostic challenge because of their variety. The Nosology and Classification of Genetic Skeletal Disorders provides an overview of recognized diagnostic entities and groups them by clinical and radiographic features and molecular pathogenesis. The aim is to provide the Genetics, Pediatrics and Radiology community with a list of recognized genetic skeletal disorders that can be of help in the diagnosis of individual cases, in the delineation of novel disorders, and in building bridges between clinicians and scientists interested in skeletal biology. In the 2010 revision, 456 conditions were included and placed in 40 groups defined by molecular, biochemical, and/or radiographic criteria. Of these conditions, 316 were associated with mutations in one or more of 226 different genes, ranging from common, recurrent mutations to "private" found in single families or individuals. Thus, the Nosology is a hybrid between a list of clinically defined disorders, waiting for molecular clarification, and an annotated database documenting the phenotypic spectrum produced by mutations in a given gene. The Nosology should be useful for the diagnosis of patients with genetic skeletal diseases, particularly in view of the information flood expected with the novel sequencing technologies; in the delineation of clinical entities and novel disorders, by providing an overview of established nosologic entities; and for scientists looking for the clinical correlates of genes, proteins and pathways involved in skeletal biology.


Related Papers

Nosology and classification of genetic skeletal disorders: 2006 revision
Andrea Superti‐Furga, Sheila Unger, and the Nosology Group of the International Skeletal Dysplasia Society|American Journal of Medical Genetics Part A|2006|344
International nosology and classification of constitutional disorders of bone (2001)
Christine M. Hall|American Journal of Medical Genetics|2002|221